DOCSLIB.ORG

Deactivation Blocks Proton Pathways in the Mitochondrial Complex I

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Deactivation Blocks Proton Pathways in the Mitochondrial Complex I Deactivation blocks proton pathways in the mitochondrial complex I Michael Röpkea, Daniel Rieplb,1, Patricia Saurab,1, Andrea Di Lucab,1, Max E. Mühlbauera,b, Alexander Jussupowa,b, Ana P. Gamiz-Hernandezb, and Ville R. I. Kailaa,b,2 aDepartment Chemie, Technische Universität München, D-85747 Garching, Germany; and bDepartment of Biochemistry and Biophysics, Stockholm University, 10691 Stockholm, Sweden Edited by Harry B. Gray, California Institute of Technology, Pasadena, CA, and approved May 11, 2021 (received for review September 16, 2020) Cellular respiration is powered by membrane-bound redox en- The recently resolved cryo-electron microscopy (cryoEM) zymes that convert chemical energy into an electrochemical pro- structures of the “deactive” mammalian complex I at around 4-Å ton gradient and drive the energy metabolism. By combining resolution highlighted conformational changes around several large-scale classical and quantum mechanical simulations with subunits close to the interface between the hydrophilic and cryo-electron microscopy data, we resolve here molecular details membrane domains of complex I. Particularly interesting are the of conformational changes linked to proton pumping in the mam- conformational changes around the membrane domain subunits malian complex I. Our data suggest that complex I deactivation ND4L, ND3, and ND6 (ND for NADH Dehydrogenase) that blocks water-mediated proton transfer between a membrane- form a bundle of 11 transmembrane (TM) helices, connected by bound quinone site and proton-pumping modules, decoupling long loop regions (14–16). Notably, it was observed that TM3 of the energy-transduction machinery. We identify a putative gating ND6 transitions from a fully α-helical form in the “active” state region at the interface between membrane domain subunits ND1 to a π-bulge around residues 60 to 65 during the deactivation and ND3/ND4L/ND6 that modulates the proton transfer by confor- process (14–16). Although the exact relevance of these confor- mational changes in transmembrane helices and bulky residues. mational transitions remains debated, it is notable that several The region is perturbed by mutations linked to human mitochon- point mutations in the vicinity of these regions have been linked drial disorders and is suggested to also undergo conformational to mitochondrial disease (11), supporting their possible func- changes during catalysis of simpler complex I variants that lack the tional relevance. Structural changes during complex I deactiva- BIOPHYSICS AND COMPUTATIONAL BIOLOGY “active”-to-“deactive” transition. Our findings suggest that confor- tion, inferred from the lack of density in the cryoEM maps mational changes in transmembrane helices modulate the proton – transfer dynamics by wetting/dewetting transitions and provide (14 16), were also suggested to take place in several loop regions important functional insight into the mammalian respiratory of the membrane domain, near the Q10 binding site tunnel, and complex I. around the supernumerary subunits NDUFA5/NDUFA10 (16, 18). However, the functional consequences of these structural cell respiration | bioenergetics | molecular simulations | QM/MM | cryoEM changes and their coupling to the biological activity still remain unclear. n mitochondrial cellular respiration, the membrane-bound Ienzyme complexes I, III, and IV convert chemical energy in- Significance to a flux of electrons toward dioxygen (1–6). The free energy of the process is transduced by pumping protons across the inner The electron transport chain of mitochondria is initiated by the mitochondrial membrane (IMM), powering oxidative phos- respiratory complex I that converts chemical energy into a phorylation and active transport (7, 8). The electron transport proton motive force to power synthesis of adenosine triphos- process is initiated by the respiratory complex I (NADH:ubi- phate. On a chemical level, complex I catalyzes elementary quinone oxidoreductase), a 45-subunit modular enzyme ma- electron and proton transfer processes that couple across large chinery that shuttles electrons from nicotinamide adenine molecular distances of >300 Å. However, under low oxygen concentrations, the respiratory chain operates in reverse mode dinucleotide (NADH) to ubiquinone (Q10) and transduces the free energy by pumping protons across the IMM, generating a and produces harmful reactive oxygen species. To avoid cell proton motive force (pmf) (1, 4–6) (Fig. 1). This proton-coupled damage, the mitochondrial complex I transitions into a deac- electron transfer reaction is fully reversible, and complex I can tive state that inhibits turnover by molecular principles that also operate in reverse electron transfer (RET) mode, powering remain elusive. By combining large-scale molecular simulations ubiquinol oxidization by consumption of the pmf. Such RET with cryo-electron microscopy data, we show here that com- modes become prevalent under hypoxic or anoxic conditions that plex I deactivation blocks the communication between proton may result, e.g., from stroke or tissue damage (9), during which pumping and redox modules by conformational and hydration the electrons leak from complex I to molecular oxygen and result changes. in the formation of reactive oxygen species (ROS) with physio- – Author contributions: V.R.I.K. designed research; M.R., D.R., P.S., A.D.L., M.E.M., A.J., and logically harmful consequences (9 11). To regulate this poten- A.P.G.-H. performed research; M.R., D.R., P.S., A.D.L., M.E.M., A.J., and A.P.G.-H. contrib- tially dangerous operation mode, the mammalian complex I can uted new reagents/analytic tools; M.R., D.R., P.S., A.D.L., M.E.M., A.J., A.P.G.-H., and V.R.I.K. analyzed data; and V.R.I.K. wrote the paper. transition into a “deactive” (D) state with low Q10-turnover ac- tivity (12, 13). Although some structural changes involved in the The authors declare no competing interest. “active”-to-“deactive” (A/D) transition were recently resolved This article is a PNAS Direct Submission. (14–16), the molecular details of how this transition regulates This open access article is distributed under Creative Commons Attribution-NonCommercial- enzyme turnover and its relevance during in vivo conditions still NoDerivatives License 4.0 (CC BY-NC-ND). remain puzzling. Moreover, it is also debated whether confor- 1D.R., P.S., and A.D.L. contributed equally to this work. mational changes linked to this transition are involved in the 2To whom correspondence may be addressed. Email: [email protected]. native catalytic cycle of all members of the complex I superfamily This article contains supporting information online at https://www.pnas.org/lookup/suppl/ or whether this transition is specific for the mitochondrial en- doi:10.1073/pnas.2019498118/-/DCSupplemental. zyme (12, 13, 17). Published July 16, 2021. PNAS 2021 Vol. 118 No. 29 e2019498118 https://doi.org/10.1073/pnas.2019498118 | 1of10 Downloaded by guest on September 28, 2021 the coupling between proton pumping- and redox-modules upon A complex I deactivation. The explored molecular principles are of general importance for elucidating energy transduction mecha- nisms in the mammalian respiratory complex I and possibly other NADH bioenergetic enzyme complexes, but also for understanding the NAD+ development of mitochondrial diseases. ND2 ND6 ND3 FMN Asp66 Glu34 Glu70 Results TM3ND6 Conformational Dynamics Modulate Water-Mediated Proton Transfer Tyr59 Lys105 Glu34 Reactions. NDUFA5 2e− To probe the dynamics of the mammalian complex I, ND4L ND1 we embedded the 45-subunit “active” state of mouse complex I NDUFA10 (19) in a mitochondrial inner lipid membrane-model with POPC/ POPE/cardiolipin (2:2:1), solvated the model with water mole- + + + + N-side H H H H cules and 150 mM NaCl, and simulated the ca. 1 million atom system in total for around 8.5 μs using atomistic MD simulations. QH2 A quinone or quinol molecule was modeled in the primary binding Q site near the N2 iron–sulfur center (20) or in a membrane-bound ND3 ND1 binding site located near the Q-tunnel kink region at ND1 that ND2 ND4L ND6 P-side ND5 ND4 was recently predicted based on simulations and validated exper- imentally (19, 21). Simulations were also performed with the SI Appendix TM3 ND3 Q-cavity left in an empty (apo) state (refer to ,Fig.S1 B C and Table S1 for simulation setups and Table S2 for modeled active state protonation states). To obtain molecular insight into the “deac- model tive” state, we constructed an intact atomistic model of this form ND6 by targeting the “active” state model toward the experimental TM3 ND6 ND4L TM4 cryoEM “deactive” density (EMD: 4356) (16) using an MD flex- TMTM44 deactive state Tyr69r69 ible fitting (MDFF) approach, followed by unrestrained MD cryoEM map D simulation for a total simulation time of ca. 6 μs (Fig. 1B). In the MDFF Tyr69ND6 Phe67Phe67 targeted MDFF simulations, the cryoEM density acts as an ex- acactivetive sstatetate ternal biasing potential that guides the dynamics of the residues, deactive state deactive state whereas for unresolved regions, the dynamics is directed only by model the biomolecular force field (22). This modeling approach is likely Phe67ND6 to provide a more balanced description of the “deactive” state and a better comparison to our “active” state simulations, as the E former state could not be experimentally resolved at the same “ ” “ 150 atomic level of detail as the active state. The obtained deac- S8 S12 6g2j ” “ ” active tive model, created from our active state simulation setup, 125 6ztq S1 S13 resembles the previously refined 3.9-Å structure of the former S2 S9 100 [Protein Data Bank (PDB) ID: 6G72] (16) for the experimentally (°) 75 resolved regions but contains more atomic detail for unresolved Φ S6 S11 parts (Fig. 1 C and D and SI Appendix, Figs. S2, S3, and S12, 50 6g72 Materials and Methods). The global dynamics observed in the MD S15 deactive 25 S10 simulations resemble the dynamics inferred from the local reso- S14 0 S7 lution of the cryoEM map (SI Appendix,Fig.S2A), including a 0 200 400 600 800 1000 Time (ns) relative twist of the hydrophilic domain relative to the membrane domain experimentally described before (14–16, 23) (SI Appendix, Fig.
Load more

Recommended publications
  • Supplementary Materials: Evaluation of Cytotoxicity and Α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids
    Supplementary Materials: Evaluation of cytotoxicity and α-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids Oxana B. Kazakova1*, Gul'nara V. Giniyatullina1, Akhat G. Mustafin1, Denis A. Babkov2, Elena V. Sokolova2, Alexander A. Spasov2* 1Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, 71, pr. Oktyabrya, 450054 Ufa, Russian Federation 2Scientific Center for Innovative Drugs, Volgograd State Medical University, Novorossiyskaya st. 39, Volgograd 400087, Russian Federation Correspondence Prof. Dr. Oxana B. Kazakova Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences 71 Prospeсt Oktyabrya Ufa, 450054 Russian Federation E-mail: [email protected] Prof. Dr. Alexander A. Spasov Scientific Center for Innovative Drugs of the Volgograd State Medical University 39 Novorossiyskaya st. Volgograd, 400087 Russian Federation E-mail: [email protected] Figure S1. 1H and 13C of compound 2. H NH N H O H O H 2 2 Figure S2. 1H and 13C of compound 4. NH2 O H O H CH3 O O H H3C O H 4 3 Figure S3. Anticancer screening data of compound 2 at single dose assay 4 Figure S4. Anticancer screening data of compound 7 at single dose assay 5 Figure S5. Anticancer screening data of compound 8 at single dose assay 6 Figure S6. Anticancer screening data of compound 9 at single dose assay 7 Figure S7. Anticancer screening data of compound 12 at single dose assay 8 Figure S8. Anticancer screening data of compound 13 at single dose assay 9 Figure S9. Anticancer screening data of compound 14 at single dose assay 10 Figure S10.
    [Show full text]
  • The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease
    International Journal of Molecular Sciences Review The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease Chunling Huang * , Ji Bian , Qinghua Cao, Xin-Ming Chen and Carol A. Pollock * Kolling Institute, Sydney Medical School, Royal North Shore Hospital, University of Sydney, St. Leonards, NSW 2065, Australia; [email protected] (J.B.); [email protected] (Q.C.); [email protected] (X.-M.C.) * Correspondence: [email protected] (C.H.); [email protected] (C.A.P.); Tel.: +61-2-9926-4784 (C.H.); +61-2-9926-4652 (C.A.P.) Abstract: Mitochondria are critical organelles that play a key role in cellular metabolism, survival, and homeostasis. Mitochondrial dysfunction has been implicated in the pathogenesis of diabetic kidney disease. The function of mitochondria is critically regulated by several mitochondrial protein kinases, including the phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1). The focus of PINK1 research has been centered on neuronal diseases. Recent studies have revealed a close link between PINK1 and many other diseases including kidney diseases. This review will provide a concise summary of PINK1 and its regulation of mitochondrial function in health and disease. The physiological role of PINK1 in the major cells involved in diabetic kidney disease including proximal tubular cells and podocytes will also be summarized. Collectively, these studies suggested that targeting PINK1 may offer a promising alternative for the treatment of diabetic kidney disease. Keywords: PINK1; diabetic kidney disease; mitochondria; mitochondria quality control; mitophagy Citation: Huang, C.; Bian, J.; Cao, Q.; 1. Introduction Chen, X.-M.; Pollock, C.A.
    [Show full text]
  • Molecular Genetic Delineation of 2Q37.3 Deletion in Autism and Osteodystrophy: Report of a Case and of New Markers for Deletion Screening by PCR
    UC Irvine UC Irvine Previously Published Works Title Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR. Permalink https://escholarship.org/uc/item/83f0x61r Journal Cytogenetics and cell genetics, 94(1-2) ISSN 0301-0171 Authors Smith, M Escamilla, JR Filipek, P et al. Publication Date 2001 DOI 10.1159/000048775 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Original Article Cytogenet Cell Genet 94:15–22 (2001) Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR M. Smith, J.R. Escamilla, P. Filipek, M.E. Bocian, C. Modahl, P. Flodman, and M.A. Spence Department of Pediatrics, University of California, Irvine CA (USA) Abstract. We recently studied a patient who meets criteria us to determine the parental origin of the deletion in our for autistic disorder and has a 2q37 deletion. Molecular cyto- patient. DNA from 8–13 unrelated individuals was used to genetic studies were carried out using DNA isolated from 22 determine heterozygosity estimates for these markers. We re- different 2q37 mapped BACs to more precisely define the view four genes deleted in our patient – genes whose known extent of the chromosome deletion. We also analyzed 2q37 functions and sites of expression in the brain and/or bone make mapped polymorphic markers. In addition DNA sequences of them candidates for involvement in autism and/or the osteo- BACs in the deletion region were scanned to identify microsa- dystrophy observed in patients with 2q37.3 deletions.
    [Show full text]
  • Assembly Factors for the Membrane Arm of Human Complex I
    Assembly factors for the membrane arm of human complex I Byron Andrews, Joe Carroll, Shujing Ding, Ian M. Fearnley, and John E. Walker1 Medical Research Council Mitochondrial Biology Unit, Cambridge CB2 0XY, United Kingdom Contributed by John E. Walker, October 14, 2013 (sent for review September 12, 2013) Mitochondrial respiratory complex I is a product of both the nuclear subunits in a fungal enzyme from Yarrowia lipolytica seem to be and mitochondrial genomes. The integration of seven subunits distributed similarly (12, 13). encoded in mitochondrial DNA into the inner membrane, their asso- The assembly of mitochondrial complex I involves building the ciation with 14 nuclear-encoded membrane subunits, the construc- 44 subunits emanating from two genomes into the two domains of tion of the extrinsic arm from 23 additional nuclear-encoded the complex. The enzyme is put together from preassembled sub- proteins, iron–sulfur clusters, and flavin mononucleotide cofactor complexes, and their subunit compositions have been characterized require the participation of assembly factors. Some are intrinsic to partially (14, 15). Extrinsic assembly factors of unknown function the complex, whereas others participate transiently. The suppres- become associated with subcomplexes that accumulate when as- sion of the expression of the NDUFA11 subunit of complex I dis- sembly and the activity of complex I are impaired by pathogenic rupted the assembly of the complex, and subcomplexes with mutations. Some assembly factor mutations also impair its activ- masses of 550 and 815 kDa accumulated. Eight of the known ex- ity (16). Other pathogenic mutations are found in all of the core trinsic assembly factors plus a hydrophobic protein, C3orf1, were subunits, and in 10 supernumerary subunits (NDUFA1, NDUFA2, associated with the subcomplexes.
    [Show full text]
  • NDUFS6 Mutations Are a Novel Cause of Lethal Neonatal Mitochondrial Complex I Deficiency Denise M
    Related Commentary, page 760 Research article NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency Denise M. Kirby,1,2,3 Renato Salemi,1 Canny Sugiana,1,3 Akira Ohtake,4 Lee Parry,1 Katrina M. Bell,1 Edwin P. Kirk,5 Avihu Boneh,1,2,3 Robert W. Taylor,6 Hans-Henrik M. Dahl,1,3 Michael T. Ryan,4 and David R. Thorburn1,2,3 1Murdoch Childrens Research Institute and 2Genetic Health Services Victoria, Royal Children’s Hospital, Melbourne, Victoria, Australia. 3Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia. 4Department of Biochemistry, LaTrobe University, Melbourne, Victoria, Australia. 5Department of Medical Genetics, Sydney Children’s Hospital, Sydney, New South Wales, Australia. 6Mitochondrial Research Group, School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom. Complex I deficiency, the most common respiratory chain defect, is genetically heterogeneous: mutations in 8 nuclear and 7 mitochondrial DNA genes encoding complex I subunits have been described. However, these genes account for disease in only a minority of complex I–deficient patients. We investigated whether there may be an unknown common gene by performing functional complementation analysis of cell lines from 10 unrelated patients. Two of the patients were found to have mitochondrial DNA mutations. The other 8 repre- sented 7 different (nuclear) complementation groups, all but 1 of which showed abnormalities of complex I assembly. It is thus unlikely that any one unknown gene accounts for a large proportion of complex I cases. The 2 patients sharing a nuclear complementation group had a similar abnormal complex I assembly profile and were studied further by homozygosity mapping, chromosome transfers, and microarray expression analysis.
    [Show full text]
  • Membrane Proteomics of Cervical Cancer Cell Lines Reveal Insights on the Process of Cervical Carcinogenesis
    INTERNATIONAL JOURNAL OF ONCOLOGY 53: 2111-2122, 2018 Membrane proteomics of cervical cancer cell lines reveal insights on the process of cervical carcinogenesis KALLIOPI I. PAPPA1,2, POLYXENI CHRISTOU3,4, AMARILDO XHOLI3, GEORGE MERMELEKAS3, GEORGIA KONTOSTATHI3,4, VASILIKI LYGIROU3,4, MANOUSOS MAKRIDAKIS3, JEROME ZOIDAKIS3 and NICHOLAS P. ANAGNOU1,4 1Cell and Gene Therapy Laboratory, Centre of Basic Research II, Biomedical Research Foundation of the Academy of Athens, 11527 Athens; 2First Department of Obstetrics and Gynecology, University of Athens School of Medicine, Alexandra Hospital, 11528 Athens; 3Biotechnology Division, Centre of Basic Research, Biomedical Research Foundation of the Academy of Athens; 4Laboratory of Biology, University of Athens School of Medicine, 11527 Athens, Greece Received March 22, 2018; Accepted May 4, 2018 DOI: 10.3892/ijo.2018.4518 Abstract. The available therapeutic approaches for cervical biological pathways relevant to malignancy, including ‘HIPPO cancer can seriously affect the fertility potential of patient; signaling’, ‘PI3K/Akt signaling’, ‘cell cycle: G2/M DNA thus, there is a pressing requirement for less toxic and damage checkpoint regulation’ and ‘EIF2 signaling’. These targeted therapies. The membrane proteome is a potential unique membrane protein identifications offer insights on a source of therapeutic targets; however, despite the signifi- previously inaccessible region of the cervical cancer proteome, cance of membrane proteins in cancer, proteomic analysis and may represent putative
    [Show full text]
  • THE FUNCTIONAL SIGNIFICANCE of MITOCHONDRIAL SUPERCOMPLEXES in C. ELEGANS by WICHIT SUTHAMMARAK Submitted in Partial Fulfillment
    THE FUNCTIONAL SIGNIFICANCE OF MITOCHONDRIAL SUPERCOMPLEXES in C. ELEGANS by WICHIT SUTHAMMARAK Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: Drs. Margaret M. Sedensky & Philip G. Morgan Department of Genetics CASE WESTERN RESERVE UNIVERSITY January, 2011 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of _____________________________________________________ candidate for the ______________________degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Dedicated to my family, my teachers and all of my beloved ones for their love and support ii ACKNOWLEDGEMENTS My advanced academic journey began 5 years ago on the opposite side of the world. I traveled to the United States from Thailand in search of a better understanding of science so that one day I can return to my homeland and apply the knowledge and experience I have gained to improve the lives of those affected by sickness and disease yet unanswered by science. Ultimately, I hoped to make the academic transition into the scholarly community by proving myself through scientific research and understanding so that I can make a meaningful contribution to both the scientific and medical communities. The following dissertation would not have been possible without the help, support, and guidance of a lot of people both near and far. I wish to thank all who have aided me in one way or another on this long yet rewarding journey. My sincerest thanks and appreciation goes to my advisors Philip Morgan and Margaret Sedensky.
    [Show full text]
  • Analyzing the Function of TRAP1 in Models of Parkinson's Disease
    Analyzing the function of TRAP1 in models of Parkinson’s disease Von der Fakultät für Mathematik, Informatik und Naturwissenschaften der RWTH Aachen University zur Erlangung des akademischen Grades einer Doktorin der Naturwissenschaften genehmigte Dissertation vorgelegt von Li Zhang aus Changchun, Jilin (China) Berichter: Universitätsprofessor Dr. med. Jörg B. Schulz Universitätsprofessor Dr. rer. nat. Marc Spehr Tag der mündlichen Prüfung: 29.01.2016 Diese Dissertation ist auf den Internetseiten der Universitätsbibliothek online verfügbar. Eidesstattliche Versicherung ___________________________Zhang, Li ___________________________ Name, Vorname Matrikelnummer (freiwillige Angabe) Ich versichere hiermit an Eides Statt, dass ich die vorliegende Arbeit/Bachelorarbeit/ Masterarbeit* mit dem Titel __________________________________________________________________________Analyzing the function of TRAP1 in models of Parkinson’s disease __________________________________________________________________________Uebersetzung: Analyse der TRAP1-Funktion in Modellen fuer Morbus Parkinson __________________________________________________________________________ selbständig und ohne unzulässige fremde Hilfe erbracht habe. Ich habe keine anderen als die angegebenen Quellen und Hilfsmittel benutzt. Für den Fall, dass die Arbeit zusätzlich auf einem Datenträger eingereicht wird, erkläre ich, dass die schriftliche und die elektronische Form vollständig übereinstimmen. Die Arbeit hat in gleicher oder ähnlicher Form noch keiner Prüfungsbehörde vorgelegen.
    [Show full text]
  • Inactivation of Mitochondrial Complex I Stimulates Chloroplast Atpase in Physcomitrella (Physcomitrium Patens)
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.20.390153; this version posted November 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Inactivation of mitochondrial Complex I stimulates chloroplast ATPase in Physcomitrella (Physcomitrium patens). Marco Mellon a, Mattia Storti a, Antoni Mateu Vera Vives a, David M. Kramer b, Alessandro Alboresi a and Tomas Morosinotto a a. Department of Biology, University of Padova, 35121 Padova, Italy b. MSU-DOE Plant Research Laboratory, Michigan State University, East Lansing, MI 48824, United States of America; Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, United States of America. Corresponding author: Tomas Morosinotto, Dipartimento di Biologia, Università di Padova, Via Ugo Bassi 58B, 35121 Padova, Italy. Tel. +390498277484, Email: [email protected] Abstract While light is the ultimate source of energy for photosynthetic organisms, mitochondrial respiration is still fundamental for supporting metabolism demand during the night or in heterotrophic tissues. Respiration is also important for the metabolism of photosynthetically active cells, acting as a sink for excess reduced molecules and source of substrates for anabolic pathways. In this work, we isolated Physcomitrella (Physcomitrium patens) plants with altered respiration by inactivating Complex I of the mitochondrial electron transport chain by independent targeting of two essential subunits. Results show that the inactivation of Complex I causes a strong growth impairment even in fully autotrophic conditions in tissues where all cells are photosynthetically active.
    [Show full text]
  • WO 2017/070647 Al 27 April 2017 (27.04.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/070647 Al 27 April 2017 (27.04.2017) P O P C T (51) International Patent Classification: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, A61K 31/455 (2006.01) C12N 15/86 (2006.01) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, A61K 31/465 (2006.01) A61P 27/02 (2006.01) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, A61K 31/19 (2006.01) A61P 27/06 (2006.01) OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, A61K 48/00 (2006.01) A61K 45/06 (2006.01) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (21) International Application Number: ZW. PCT/US2016/058388 (84) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of regional protection available): ARIPO (BW, GH, 24 October 2016 (24.10.201 6) GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (25) Filing Language: English TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (26) Publication Language: English DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (30) Priority Data: LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, 62/245,467 23 October 2015 (23.
    [Show full text]
  • Electron Transport Chain Activity Is a Predictor and Target for Venetoclax Sensitivity in Multiple Myeloma
    ARTICLE https://doi.org/10.1038/s41467-020-15051-z OPEN Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma Richa Bajpai1,7, Aditi Sharma 1,7, Abhinav Achreja2,3, Claudia L. Edgar1, Changyong Wei1, Arusha A. Siddiqa1, Vikas A. Gupta1, Shannon M. Matulis1, Samuel K. McBrayer 4, Anjali Mittal3,5, Manali Rupji 6, Benjamin G. Barwick 1, Sagar Lonial1, Ajay K. Nooka 1, Lawrence H. Boise 1, Deepak Nagrath2,3,5 & ✉ Mala Shanmugam 1 1234567890():,; The BCL-2 antagonist venetoclax is highly effective in multiple myeloma (MM) patients exhibiting the 11;14 translocation, the mechanistic basis of which is unknown. In evaluating cellular energetics and metabolism of t(11;14) and non-t(11;14) MM, we determine that venetoclax-sensitive myeloma has reduced mitochondrial respiration. Consistent with this, low electron transport chain (ETC) Complex I and Complex II activities correlate with venetoclax sensitivity. Inhibition of Complex I, using IACS-010759, an orally bioavailable Complex I inhibitor in clinical trials, as well as succinate ubiquinone reductase (SQR) activity of Complex II, using thenoyltrifluoroacetone (TTFA) or introduction of SDHC R72C mutant, independently sensitize resistant MM to venetoclax. We demonstrate that ETC inhibition increases BCL-2 dependence and the ‘primed’ state via the ATF4-BIM/NOXA axis. Further, SQR activity correlates with venetoclax sensitivity in patient samples irrespective of t(11;14) status. Use of SQR activity in a functional-biomarker informed manner may better select for MM patients responsive to venetoclax therapy. 1 Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA, USA.
    [Show full text]
  • SARS-Cov-2 Nucleocapsid Protein Attenuates Stress Granule Formation and Alters Gene Expression Via Direct Interaction with Host Mrnas
    SARS-CoV-2 Nucleocapsid protein attenuates stress granule formation and alters gene expression via direct interaction with host mRNAs Syed Nabeel-Shah1,2,5, Hyunmin Lee1,3,5, Nujhat Ahmed1,2,5, Edyta Marcon1,5, Shaghayegh Farhangmehr1,2, Shuye Pu1, Giovanni L. Burke1,2, Kanwal Ashraf1, Hong Wei4, Guoqing Zhong1, Hua Tang1, Jianyi Yang4, Benjamin J. Blencowe1,2, Zhaolei Zhang1,2,3, Jack F. Greenblatt1,2, * 1. Donnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada 2. Department of Molecular Genetics, University of Toronto, Toronto, M5S 1A8, Canada. 3. Department of Computer Sciences, University of Toronto, Toronto, M5S 1A8, Canada. 4. School of Mathematical Sciences, Nankai University, Tianjin 300071, China 5 These authors contributed equally to this work * Corresponding author: Jack F. Greenblatt; Email: [email protected] Keywords: SARS-CoV-2, COVID-19, Nucleocapsid N protein, Stress granules, G3BP1 and G3BP2, Gene expression regulation, host mRNA-binding Supplemental Figures Extended Figure 1: Dot plot overview of the interaction partners identified with 21 SARS-CoV- 2 proteins expressed in HEK293 cells. Inner circle color represents the average spectral count, the circle size maps to the relative prey abundance across all samples shown, and the circle outer edge represents the SAINT FDR. Legend is provided. Extended Figure 2: KEGG pathway (A) and Biological processes (B) enrichment analysis using cellular proteins identified as high confidence (FDR<1%) interaction partners for the SARS- CoV-2 proteins. Only top 10 most significant terms are shown (Q0.05). Darker nodes are more significantly enriched gene sets. Bigger nodes represent larger gene sets. Thicker edges represent more overlapped genes.
    [Show full text]